Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes

Journal of Endocrinology

Volumn 169, Issue 3, 2001, Pages 437-445

  Kino, T ^a   Chrousos, G P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; GENE PRODUCT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HORMONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; MUTANT PROTEIN; TRANSACTIVATOR PROTEIN; VPR PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BASE PAIRING; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CODON; CONTROLLED STUDY; CUSHING SYNDROME; DONOR; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; HETEROZYGOTE; HOMEOSTASIS; HORMONE ACTION; HORMONE RESISTANCE; HORMONE SENSITIVITY; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERADRENOCORTICISM; HYPERSENSITIVITY; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INTRON; LIGAND BINDING; LONG TERMINAL REPEAT; METABOLISM; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PSEUDOHYPOALDOSTERONISM; REGULATORY MECHANISM; RNA SPLICING; SYNDROME; TRANSCRIPTION TERMINATION; VIRUS PROLIFERATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADRENOCORTICAL HYPERFUNCTION; DRUG RESISTANCE; HUMANS; MUTATION; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SYNDROME;

EID: 0034965716     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1690437     Document Type: Article

References (69)

1. Syndromes of glucocorticoid and mineralocorticoid resistance
2. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism
3. Polymorphisms of amiloride-sensitive sodium channel subunits in five sporadic cases of pseudohypoaldosteronism: Do they have pathologic potential?
4. Aldosterone-receptor deficiency in pseudohypoaldosteronism
5. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor
6. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro
7. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
8. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
9. Interaction of steroid hormone receptors with the transcription initiation complex
10. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids
11. Epithelial sodium channel related to proteins involved in neurodegeneration
12. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits
13. Glucocorticoid resistance
14. Modulation of immunoreactive somatomedin-C levels by sex steroids
15. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1
16. A salt wasting syndrome in infancy
17. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
18. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease
19. Syndromes of glucocorticoid resistance
20. Mechanism of steroid hormones
21. Disorders of glucose metabolism in patients infected with human immunodeficiency virus
22. HIV-1, Vpr and the cell cycle
23. Tat-mediated delivery of heterologous proteins into cells
24. Nuclear import of human immunodeficiency virus type-1 preintegration complexes
25. Glucocorticoid and mineralocorticoid receptors: Biology and clinical relevance
26. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: Toward a redefinition of mineralocorticoid action
27. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I
28. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women
29. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34 cdc2 activity
30. Functional and structural characterization of synthetic HIV-1 vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest
31. Primary structure and expression of a functional human glucocorticoid receptor cDNA
32. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance
33. Primary cortisol resistance accompanied by a reduction in glucocorticoid receptors in two members of the same family
34. Structure, function and regulation of Na,K-ATPase in the kidney
35. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene
36. Cushing's disease preceded by generalized glucocorticoid resistance: Clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation
37. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor
38. Corticosteroids and the brain
39. Studies of body composition and fat distribution in HIV-infected and control subjects
40. Familial cortisol resistance: Differential diagnostic and therapeutic aspects
41. Cortisol receptor resistance: The variability of its clinical presentation and response to treatment
42. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta
43. Induction of cell differentiation by human immunodeficiency virus 1 vpr
44. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1
45. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions
46. A mutation of the glucocorticoid receptor in primary cortisol resistance
47. The nuclear receptor superfamily: The second decade
48. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
49. Decreased deoxyribonucleic acid binding of glucocorticoid-receptor complex in cultured skin fibroblasts from a patient with the glucocorticoid resistance syndrome
50. Glucocorticoids and the immune function in the human immunodeficiency virus infection: A study in hypercortisolemic and cortisol-resistant patients
51. Pseudohypo-aldosteronism: Multiple target organ unresponsiveness to mineralocorticoid hormones
52. Altered cortisol response and hippocampal atrophy in pediatric HIV disease
53. The molecular biology of HIV-1
54. The natural history of salt-wasting disorders of adrenal and renal origin
55. Transactivation and synergistic properties of the mineralocorticoid receptor: Relationship to the glucocorticoid receptor
56. Pseudohypoaldosteronism: Severe salt wasting in infancy caused by generalized mineralocorticoid unresponsiveness
57. Cooperative interaction between HIV-1 regulatory proteins tat and vpr modulates transcription of the viral genome
58. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
59. Human immunodeficiency virus-associated myopathy: Analysis of 11 patients
60. Pseudohypoaldosteronism: A review and report of two new cases
61. Functional interactions between Stat5 and the glucocorticoid receptor
62. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families
63. Primary glucocorticoid receptor defect with likely familial involvement
64. Spontaneous hypercortisolism without Cushing's syndrome
65. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection
66. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy
67. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism
68. Human mineralocorticoid receptor genomic structure and identification of expressed isoforms